1,432
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Cortico-thalamo-striatal circuit components’ volumes and their correlations differ significantly among patients with obsessive–compulsive disorder: a case–control MRI study

ORCID Icon, ORCID Icon, , &
Pages 162-170 | Received 13 Dec 2018, Accepted 10 Feb 2019, Published online: 27 Feb 2019

References

  • Rasmussen SA, Eisen JL. The epidemiology and clinical features of obsessive compulsive disorder. Psychiatr Clin North Am. 1992;15:743–758. doi: 10.1016/S0193-953X(18)30205-3
  • Abramowitz JS, Taylor S, McKay D. Obsessive-compulsive disorder. Lancet. 2009;8(374):491–499. doi: 10.1016/S0140-6736(09)60240-3
  • Aouizerate B, Guehl D, Cuny E, et al. Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog Neurobiol. 2004;72:195–221. doi: 10.1016/j.pneurobio.2004.02.004
  • Whiteside SP, Port JD, Deacon BJ, et al. A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res. 2006;146:137–147. doi: 10.1016/j.pscychresns.2005.12.006
  • Menzies L, Chamberlain SR, Laird AR, et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev. 2008;32(3):525–549. doi: 10.1016/j.neubiorev.2007.09.005
  • Atmaca M, Yildirim B H, Ozdemir B H, et al. Volumetric MRI assessment of brain regions in patients with refractory obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1051–1057. doi: 10.1016/j.pnpbp.2006.03.033
  • Jung WH, Kang DH, Kim E, et al. Abnormal corticostriatal-limbic functional connectivity in obsessive-compulsive disorder during reward processing and resting-state. Neuroimage Clin. 2013;3:27–38. doi: 10.1016/j.nicl.2013.06.013
  • Atmaca M, Yildirim H, Ozdemir H, et al. Volumetric MRI study of key brain regions implicated in obsessive-compulsive disorder. ProgNeuropsychopharmacol Biol Psychiatry. 2007;31:46–52. doi: 10.1016/j.pnpbp.2006.06.008
  • Choi JS, Kang DH, Kim JJ, et al. Left anterior subregion of orbitofrontal cortex volume reduction and impaired organizational strategies in obsessive-compulsive disorder. J Psychiatr Res. 2004;38:193–199. doi: 10.1016/j.jpsychires.2003.08.001
  • Kang DH, Kim JJ, Choi JS, et al. Volumetric investigation of the frontal-subcortical circuitry in patients with obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci. 2004;16:342–349. doi: 10.1176/jnp.16.3.342
  • Pujol J, Soriano-Mas C, Alonso P, et al. Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry. 2004;61:720–730. doi: 10.1001/archpsyc.61.7.720
  • Moon CM, Kim BC, Jeong GW. Associations of neurofunctional, morphometric and metabolic abnormalities with clinical symptom severity and recognition deficit in obsessive-compulsive disorder. J Affect Disord. 2018;227:603–612. doi: 10.1016/j.jad.2017.11.059
  • Gilbert AR, Moore GJ, Keshavan MS, et al. Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch Gen Psychiatry. 2000;57:449–456. doi: 10.1001/archpsyc.57.5.449
  • Matsumoto R, Ito H, Takahashi H, et al. Reduced gray matter volume of dorsal cingulate cortex in patients with obsessive-compulsive disorder: a voxel-based morphometric study. Psychiatry Clin Neurosci. 2010;64:541–547. doi: 10.1111/j.1440-1819.2010.02125.x
  • Huey ED, Zahn R, Krueger F, et al. A psychological and neuroanatomical model of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci. 2008;20:390–408. doi: 10.1176/jnp.2008.20.4.390
  • Lochner C, Fouché JP, du Plessis S, et al. Evidence for fractional anisotropy and mean diffusivity white matter abnormalities in the internal capsule and cingulum in patients with obsessive-compulsive disorder. J Psychiatry Neurosci. 2012;37:193–199. doi: 10.1503/jpn.110059
  • Zarei M, Mataix-Cols D, Heyman I, et al. Changes in gray matter volume and white matter microstructure in adolescents with obsessive-compulsive disorder. Biol Psychiatry. 2011;70:1083–1090. doi: 10.1016/j.biopsych.2011.06.032
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM IV). 4th ed. Washington (DC): American Psychiatric Press; 1994.
  • Çorapçıoğlu A, Aydemir Ö, Yıldız M. DSM-IV Eksen I bozukluklarına Göre Türkçe Yapılandırılmış Klinik Değerlendirmenin Güvenirliği. İlaç ve Tedavi Dergisi. 1999;12:33–36.
  • Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown obsessive-compulsive scale: development, use and reliability. Arch Gen Psychiatry. 1989;46:1006–1011. doi: 10.1001/archpsyc.1989.01810110048007
  • Tek C, Ulug B, Rezaki BG, et al. Yale-Brown obsessive compulsive scale and US National Institute of Mental Health Global obsessive compulsive Scale in Turkish: reliability and validity. Acta Psychiatr Scand. 1995;91:410–413. doi: 10.1111/j.1600-0447.1995.tb09801.x
  • Cardoner N, Soriano-Mas C, Pujol J, et al. Brain structural correlates of depressive comorbidity in obsessive-compulsive disorder. Neuroimage. 2007;38:413–421. doi: 10.1016/j.neuroimage.2007.07.039
  • Hayasaka Y, Purgato M, Magni LR, et al. Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials. J Affect Disord. 2015;180:179–184. doi: 10.1016/j.jad.2015.03.021
  • Jackson GD, Duncan JS. MRI anatomy: a new angle on the brain. New York (NY): Churchill Livingstone; 1996.
  • Patel VH, Friedman L. MRI of the brain: normal anatomy and normal variants. Saunders; 1997.
  • Portas CM, Goldstein JM, Shenton ME, et al. Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol Psychiatry. 1998;43:649–659. doi: 10.1016/S0006-3223(97)00339-9
  • Lacerda AL, Hardan AY, Yorbik O, et al. Measurement of the orbitofrontal cortex: a validation study of a new method. Neuroimage. 2003;19:665–673. doi: 10.1016/S1053-8119(03)00137-X
  • Sass JO, Forstner R, Sperl W. 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: impaired catabolism of isoleucine presenting as neurodegenerative disease. Brain Dev. 2004;26:12–14. doi: 10.1016/S0387-7604(03)00071-8
  • Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am. 2000;23(3):563–586. doi: 10.1016/S0193-953X(05)70181-7
  • Saxena S, Bota RG, Brody AL. Brain-behavior relationships in obsessive-compulsive disorder. Semin Clin Neuropsychiatry. 2001;6:82–101. doi: 10.1053/scnp.2001.21833
  • Graybiel AM, Rauch SL. Toward a neurobiology of obsessive-compulsive disorder. Neuron. 2000;28(2):343–347. doi: 10.1016/S0896-6273(00)00113-6
  • Radua J, Mataix-Cols D. Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder. Br J Psychiatry. 2009;195(5):393–402. doi: 10.1192/bjp.bp.108.055046
  • Radua J, van den Heuvel OA, Surguladze S, et al. Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders. Arch Gen Psychiatry. 2010;67:701–711. doi: 10.1001/archgenpsychiatry.2010.70
  • Rotge JY, Guehl D, Dilharreguy B, et al. Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biol Psychiatry. 2009;65:75–83. doi: 10.1016/j.biopsych.2008.06.019
  • Rotge JY, Langbour N, Jaafari N, et al. Anatomical alterations and symptom-related functional activity in obsessive-compulsive disorder are correlated in the lateral orbitofrontal cortex. Biol Psychiatry. 2010;67:e37–e38. doi: 10.1016/j.biopsych.2009.10.007
  • Carter CS, Botvinick MM, Cohen JD. The contribution of the anterior cingulate cortex to executive processes in cognition. Rev Neurosci. 1999;10:49–57. doi: 10.1515/REVNEURO.1999.10.1.49
  • Botvinick M, Nystrom LE, Fissell K, et al. Conflict monitoring versus selection-for-action in anterior cingulate cortex. Nature. 1999;11:179–181. doi: 10.1038/46035
  • Szeszko PR, Ardekani BA, Ashtari M, et al. White matter abnormalities in obsessive-compulsive disorder: a diffusiontensor imaging study. Arch Gen Psychiatry. 2005;62:782–790. doi: 10.1001/archpsyc.62.7.782
  • Venkatasubramanian G, Zutshi A, Jindal S, et al. Comprehensive evaluation of structure abnormalities in drug-naive, adult patients with obsessive-compulsive disorder: a surface-based morphometry study. J Psychiatr Res. 2012;46:1161–1168. doi: 10.1016/j.jpsychires.2012.06.003
  • Alvarenga PG, do Rosario MC, Batistuzzo MC, et al. Obsessive-compulsive symptom dimensions correlate to spesific gray matter volumes in treatment-naive patients. J Psychiatr Res. 2012;46:1635–1642. doi: 10.1016/j.jpsychires.2012.09.002
  • Kim JJ, Lee MC, Kim J, et al. Grey matter abnormalities in obsessive-compulsive disorder: statistical parametric mapping of segmented magnetic resonance images. Br J Psychiatry. 2001;179:330–334. doi: 10.1192/bjp.179.4.330
  • Valente AA, Miguel EC, Castro CC, et al. Regional gray matter abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study. Biol Psychiatry. 2005;58(6):479–487. doi: 10.1016/j.biopsych.2005.04.021
  • Christian CJ, Lencz T, Robinson DG, et al. Gray matter structural alterations in obsessive-compulsive disorder: relationship to neuropsychological functions. Psychiatry Res. 2008;164:123–131. doi: 10.1016/j.pscychresns.2008.03.005
  • van den Heuvel OA, Remijnse PL, Mataix-Cols D, et al. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain. 2009;132:853–868. doi: 10.1093/brain/awn267
  • Hoexter MQ, de Souza Duran FL, D'Alcante CC, et al. Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: a randomized clinical trial. Neuropsychopharmacology. 2012;37:734–745. doi: 10.1038/npp.2011.250
  • Jenike MA, Breiter HC, Baer L, et al. Cerebral structural abnormalities in obsessive-compulsive disorder. A quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry. 1996;53:625–632. doi: 10.1001/archpsyc.1996.01830070073011
  • Baxter LR. Neuroimaging studies of obsessive compulsive disorder. Psychiatr Clin North Am. 1992;15:871–884. doi: 10.1016/S0193-953X(18)30215-6
  • Modell JG, Mountz JM, Curtis GC, et al. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci. 1989;1:27–36. doi: 10.1176/jnp.1.3.340-a
  • Szechtman H, Ahmari SE, Beninger RJ, et al. Obsessive-compulsive disorder: insights from animal models. Neurosci Biobehav Rev. 2017;76:254–279. doi: 10.1016/j.neubiorev.2016.04.019
  • Posner MI, Dehaene S. Attentional networks. Trends Neurosci. 1994;17:75–79. doi: 10.1016/0166-2236(94)90078-7
  • Rosenberg DR, Keshavan MS. A.E. Bennett Research Award. Toward a neurodevelopmental model of of obsessive–compulsive disorder. Biol Psychiatry. 1998;1(43):623–640. doi: 10.1016/S0006-3223(97)00443-5
  • Yoo SY, Roh MS, Choi JS, et al. Voxel-based morphometry study of gray matter abnormalities in obsessive-compulsive disorder. J Korean Med Sci. 2008;23:24–30. doi: 10.3346/jkms.2008.23.1.24
  • Herrero MT, Barcia C, Navarro JM. Functional anatomy of thalamus and basal ganglia. Childs Nerv Syst. 2002;18:368–404. doi: 10.1007/s00381-002-0604-1
  • Rotge JY, Dilharreguy B, Aouizerate B, et al. Inverse relationship between thalamic and orbitofrontal volumes in obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:682–687. doi: 10.1016/j.pnpbp.2009.03.011
  • Taylor-Robinson SD, Weeks RA, Sargentoni J, et al. Evidence for glutamate excitotoxicity in Huntington's disease with proton magnetic resonance spectroscopy. Lancet. 1994;343:1170. doi: 10.1016/S0140-6736(94)90280-1
  • Carlsson ML. On the role of cortical glutamate in obsessive-compulsive disorder and attention-deficit hyperactivity disorder, two phenomenologically antithetical conditions. Acta Psychiatr Scand. 2000;102:401–413. doi: 10.1034/j.1600-0447.2000.102006401.x